{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["24(4)"],"submitter":["Otten MH"],"pubmed_abstract":["<h4>Objectives</h4>To investigate neurocognitive, psychosocial, and quality of life (QoL) outcomes in children with Multisystem Inflammatory Syndrome in Children (MIS-C) seen 3-6 months after PICU admission.<h4>Design</h4>National prospective cohort study March 2020 to November 2021.<h4>Setting</h4>Seven PICUs in the Netherlands.<h4>Patients</h4>Children with MIS-C (0-17 yr) admitted to a PICU.<h4>Interventions</h4>None.<h4>Measurements and main results</h4>Children and/or parents were seen median (interquartile range [IQR] 4 mo [3-5 mo]) after PICU admission. Testing included assessment of neurocognitive, psychosocial, and QoL outcomes with reference to Dutch pre-COVID-19 general population norms. Effect sizes (Hedges' g ) were used to indicate the strengths and clinical relevance of diff"],"journal":["Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies"],"pagination":["289-300"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10072052"],"repository":["biostudies-literature"],"pubmed_title":["Neurocognitive, Psychosocial, and Quality of Life Outcomes After Multisystem Inflammatory Syndrome in Children Admitted to the PICU."],"pmcid":["PMC10072052"],"pubmed_authors":["Otten MH","Roeleveld PP","Kneyber MCJ","Buddingh EP","van Schooneveld M","Buysse CMP","Humblet M","Walker JC","von Asmuth EGJ","Ketharanathan N","Krabben G","van Woensel JBM","Hogenbirk K","Wassenberg R","van Zwol A","Dulfer K","Maebe S","van Waardenburg D","Maas NM","de Wit E","de Hoog M","Terheggen-Lagro SWJ","Haverman L","Timmers-Raaijmaakers B","Oostrom KJ","Joosten KFM","de Sonnaville ESV","Bunker-Wiersma HE","Knoester H","Lemson J","Wolthuis DW"],"additional_accession":[]},"is_claimable":false,"name":"Neurocognitive, Psychosocial, and Quality of Life Outcomes After Multisystem Inflammatory Syndrome in Children Admitted to the PICU.","description":"<h4>Objectives</h4>To investigate neurocognitive, psychosocial, and quality of life (QoL) outcomes in children with Multisystem Inflammatory Syndrome in Children (MIS-C) seen 3-6 months after PICU admission.<h4>Design</h4>National prospective cohort study March 2020 to November 2021.<h4>Setting</h4>Seven PICUs in the Netherlands.<h4>Patients</h4>Children with MIS-C (0-17 yr) admitted to a PICU.<h4>Interventions</h4>None.<h4>Measurements and main results</h4>Children and/or parents were seen median (interquartile range [IQR] 4 mo [3-5 mo]) after PICU admission. Testing included assessment of neurocognitive, psychosocial, and QoL outcomes with reference to Dutch pre-COVID-19 general population norms. Effect sizes (Hedges' g ) were used to indicate the strengths and clinical relevance of diff","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2025-04-04T10:41:36.631Z","creation":"2025-04-04T10:41:36.631Z"},"accession":"S-EPMC10072052","cross_references":{"pubmed":["36688688"],"doi":["10.1097/PCC.0000000000003180"]}}